Search

1222498
1230819
1201004
1195994
393884
ScimathUS
The South African Tuberculosis Vaccine Initiative will be offering a limited number of bursaries to cover the Registration Fees associated with the SciMathUS Program, a university preparation program which is offered by the Stellenbosch University...
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...

News

Tuesday, 21 August 2018
20 August 2018 Research Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes

Associate Professor Tom Scriba has co-authored a research paper titled: "Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes" appearing in the Frontiers journal.

Publication Date:
Tuesday, August 21, 2018 - 11:15
17 August 2018 Research: Prospects for a vaccine to prevent HIV related Tuberculosis

SATVI Authors dr Elisa Nemes, Professor Mark Hatherill and Associate Professor Tom Scriba have published a paper titled: "Prospects for a vaccine to prevent HIV related Tuberculosis" appearing in the Current opinions in HIV/AIDS journal.

Publication Date:
Monday, August 20, 2018 - 15:45
Celebrating the legacy of Nelson Mandela

For this year’s Mandela Day the South African Tuberculosis Vaccine Initiative (SATVI) has announced its support for community based soup kitchens in the Cape Winelands District.

Publication Date:
Thursday, July 19, 2018 - 12:45
Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines.

Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) and the Desmond Tutu HIV Foundation have announced publication in the New England Journal of Medicine of the results of an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained TB infections in high-risk adolescents. our latest TB vaccine clinical trial have been published in the New England Journal of Medicine.

Publication Date:
Thursday, July 12, 2018 - 08:15

Pages